https://cogentia.kinsta.cloud/case-study/imf-the-innovative-medicines-fund-or-the-interim-medicines-fund/ 2026-10-13T08:26:16+00:00 https://cogentia.kinsta.cloud/case-study/nices-proportionate-approach-is-it-working-time-to-access-for-cost-comparison-vs-single-technology-appraisals/ 2026-10-13T11:31:39+00:00 https://cogentia.kinsta.cloud/case-study/cost-effectiveness-of-lebrikizumab-compared-with-other-systemic-biologics-for-moderate-to-severe-atopic-dermatitis-in-the-uk/ 2026-10-13T11:31:48+00:00